| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105729 Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents |
| 04/29/2010 | US20100105727 Novel benzamide derivatives and process for the prepartion thereof |
| 04/29/2010 | US20100105726 Imidazole derivatives that induce apoptosis and their therapeutic uses |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105700 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors |
| 04/29/2010 | US20100105694 Substituted pyrazinone derivatives for use as a medicine |
| 04/29/2010 | US20100105693 Modulators of Muscarinic Receptors |
| 04/29/2010 | US20100105684 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/29/2010 | US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105680 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 04/29/2010 | US20100105679 5-pyridinone substituted indazoles |
| 04/29/2010 | US20100105674 Chemical Compounds |
| 04/29/2010 | US20100105667 Quinoxaline- and Quinoline-Carboxamide Derivatives |
| 04/29/2010 | US20100105665 Renin inhibitors |
| 04/29/2010 | US20100105664 Organic compounds |
| 04/29/2010 | US20100105663 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/29/2010 | US20100105660 Organic compounds75074 |
| 04/29/2010 | US20100105659 2-aminopyridine analogs as glucokinase activators |
| 04/29/2010 | US20100105655 Novel compounds 515 |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | US20100105651 Antagonists of sns sodium channels |
| 04/29/2010 | US20100105650 Substituted isoquinoline and isoquinolinone derivatives |
| 04/29/2010 | US20100104659 Benzopyranopyrazoles |
| 04/29/2010 | US20100104534 Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 04/29/2010 | US20100104504 Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation |
| 04/29/2010 | US20100101643 Compound, photoelectric converter and photoelectrochemical cell |
| 04/29/2010 | CA2741349A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain |
| 04/29/2010 | CA2740583A1 C-met protein kinase inhibitors |
| 04/29/2010 | CA2739946A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/28/2010 | EP2180020A1 Indolium compound and optical recording material using the compound |
| 04/28/2010 | EP2179997A1 Sulfonamide compound, and crystal thereof |
| 04/28/2010 | EP2178862A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178861A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 04/28/2010 | EP2178860A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178859A2 Condensed anthranilamide derivatives as insectisides |
| 04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
| 04/28/2010 | EP2178856A1 Bispidon ligands and the metal complexes thereof |
| 04/28/2010 | EP2178842A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178839A2 New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 04/28/2010 | EP2178838A2 New thrombin function compounds and pharmaceutical compositions based on them |
| 04/28/2010 | EP2178835A1 Novel substituted piperidones as hsp inducers |
| 04/28/2010 | EP2029547B1 Fxr agonists |
| 04/28/2010 | EP1907366B1 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 04/28/2010 | EP1902047B1 Carboxamide compound and use of the same |
| 04/28/2010 | EP1753739B1 Imidazol-2-one compounds useful in the treatment of various disorders |
| 04/28/2010 | EP1678162B1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 04/28/2010 | EP1643989B1 Cis-imidazolines as mdm2 inhibitors |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | CN1856305B Pyridine derivatives as urotensin II antagonists |
| 04/28/2010 | CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |
| 04/27/2010 | US7705161 cyclization of N-acylhydrazone |
| 04/27/2010 | US7705160 Method for preparing 3-halo-4,5-dihydro-1H-pyrazoles |
| 04/27/2010 | US7705153 chemokine coupled receptor 3 (CCR3); treating asthma; 1-(heteroarylcarbonyl)-4-piperidino-piperidine compounds |
| 04/27/2010 | US7705149 Benzoimidazole compounds |
| 04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 04/27/2010 | US7705146 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with amide anion and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide |
| 04/27/2010 | US7705143 Benzoimidazole compounds |
| 04/27/2010 | US7705031 Benzimidazoles useful as modulators of ion channels |
| 04/27/2010 | US7705030 2-Amino-5-[3-(2fluoropyridin-3-yl)phenyl]-3methyl-5-[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-3,5-dihydro-4H-imidazol-4-one; Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits |
| 04/27/2010 | US7705023 Indoles useful in the treatment of inflammation |
| 04/27/2010 | US7705022 IDO inhibitors and methods of use thereof |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7705017 Compounds for treatment of neurodegenerative diseases |
| 04/27/2010 | US7705007 Cis-imidazolines |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |
| 04/27/2010 | US7704995 Protein kinase modulators and methods of use |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2495880C Pyrimidine derivatives and their use as cb2 modulators |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2408649C Piperazinedione compounds |
| 04/27/2010 | CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 04/22/2010 | WO2010045377A2 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 04/22/2010 | WO2010045306A2 Azine derivatives and methods of use thereof |
| 04/22/2010 | WO2010045276A2 Azabenzimidazolones |
| 04/22/2010 | WO2010045212A2 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010044885A2 Soluble mtor complexes and modulators thereof |
| 04/22/2010 | WO2010044585A2 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 04/22/2010 | WO2010044411A1 Phenylisonicotinic acid derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same |
| 04/22/2010 | WO2010044404A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | WO2010043721A1 Oxidase inhibitors and their use |
| 04/22/2010 | WO2010043601A1 Process for the preparation of enantiomerically enriched proton pump inhibitors |
| 04/22/2010 | WO2010043315A1 Pesticidal (hetero) arylpyrrolidines |